Literature DB >> 9359620

Modeling drug-melanin interaction with theoretical linear solvation energy relationships.

A H Lowrey1, G R Famini, V Loumbev, L Y Wilson, J M Tosk.   

Abstract

The affinity of drugs and other xenobiotic agents for melanin is a well-known phenomenon, often occurring with serious physiological consequences. For example, the interaction of anti-psychotic drugs with neuromelanin may play a pivotal role in the induction of extrapyramidal movement disorders associated with the chronic administration of phenothiazine and other neuroleptic agents. Little, however, is known about the complete nature of melanin-drug binding and the impact of these interactions on the physico-chemical properties of melanin. Data, such as binding affinities, can be analyzed using recently developed computational methods that combine mathematical models of chemical structure with statistical analysis. In particular, theoretical linear solvation energy relationships provide a convenient model for understanding and predicting biological, chemical, and physical properties. By using this modeling technique, drug-melanin binding of a set of 16 compounds has been analyzed with correlation analysis and a set of theoretical molecular parameters in order to better understand and characterize drug-melanin interactions. The resulting correlation equation supports a charge transfer model for drug-melanin complex formation and can also be used to estimate binding constants for related compounds.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9359620     DOI: 10.1111/j.1600-0749.1997.tb00684.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  3 in total

1.  Binding of memantine to melanin: influence of type of melanin and characteristics.

Authors:  Martin J Koeberle; Patrick M Hughes; Graham G Skellern; Clive G Wilson
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

Review 2.  Melanins as Sustainable Resources for Advanced Biotechnological Applications.

Authors:  Hanaa A Galeb; Emma L Wilkinson; Alison F Stowell; Hungyen Lin; Samuel T Murphy; Pierre L Martin-Hirsch; Richard L Mort; Adam M Taylor; John G Hardy
Journal:  Glob Chall       Date:  2020-11-25

3.  Theoretical calculations of molecular descriptors for anticancer activities of 1, 2, 3-triazole-pyrimidine derivatives against gastric cancer cell line (MGC-803): DFT, QSAR and docking approaches.

Authors:  Rhoda Oyeladun Oyewole; Abel Kolawole Oyebamiji; Banjo Semire
Journal:  Heliyon       Date:  2020-05-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.